Pharmacists in Mangham, LA Accepting Medicare
2 Pharmacists found. Showing 1 - 2
 Andrea Spruell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 252 Highway 132, Mangham, LA 71259 Phone: 318-248-3338 |
Mrs. Kayla D Bridges, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 252 Highway 132, Mangham, LA 71259 Phone: 318-248-3338 Fax: 318-248-3399 |
News Archive
Funding too low for paediatric oncology research
At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today.
NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.
New guideline supports hypofractionated radiation therapy for men with prostate cancer
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most common malignancy among American men.
Victhom second-quarter revenues decrease 94.4% to $27,901
Victhom Human Bionics Inc. today reported its second quarter 2010 financial results.
Chemotherapy options improve for patients with advanced colorectal cancer
For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC).
› Verified 4 days ago